If you are experienced in the management and delivery of real-world evidence trials, with a highly analytical and meticulous approach, then we want to hear from you!
Join us to help improve peoples’ lives and make healthcare better for everyone!
Pharmanovia is a dynamic, fast-growing international pharmaceutical company with a portfolio of over 20 brands across more than 140 markets. Our mission is to improve patient health globally through the revitalisation of niche, tried-and-trusted medicines.
Since its inception in 2013, Pharmanovia has grown consistently year on year, focusing on delivering high-quality branded prescription medicines to patients, prescribers, and healthcare providers across the world. Our growth has enabled the company to reinvest in its products, brands, people, and to give back to its communities. A people business with a strong, supportive culture that encourages innovation and entrepreneurial spirit, our team comprises over 300 employees and 29 nationalities, operating from offices in the UK, Denmark, Netherlands, Switzerland, U.A.E., India, Singapore, Italy, and South Korea.
We are an agile and imaginative global specialty pharma business and a preferred partner for innovator pharma companies, instigating a paradigm shift in the life cycle management of iconic medicines. We seek to extensively engage with clinical communities to communicate product improvements and prioritise environmental, social, and governance considerations across the business and workforce.
Pharmanovia’s therapeutic areas include Cardiovascular, Oncology, Endocrinology and Neurology.
Reporting to Head of Clinical Development, as the RWE Associate Director you will be responsible for the overall management of RWE trials, from protocol development to study completion. Working closely with different departments like market access, strategic marketing, medical affairs, etc, you will oversee the design, execution, analysis, reporting and publication of all RWE studies required to deliver the pipeline of life cycle management strategies, as well as novel products and new chemical entities being licenced into the pipeline.
In your role, you will also act as the main point of interaction with external CROs, help in identifying best partners to appoint for trial execution and support, as well as ensuring each RWE study protocol is designed with scientific integrity with the endpoints clearly addressing the study objectives in line with the clinical development/evidence plan and business needs.
Candidates with at least 8 years’ experience in RWE research, or related fields, are likely to have the skills and experience required for this role, which requires an in-depth knowledge of biostatistics, epidemiology and the collection and analysis of actual data. We are also looking for:
We offer a competitive salary plus bonus and rewards package including holiday, health & wellbeing program, employee recognition awards, social events, pension scheme and hybrid working.
By applying for this role, your details will be sent to Ortolan People, who are engaged to provide recruitment support in processing applications. We will endeavour to respond to all applicants within three working days. Occasionally for roles with a very high volume of applicants, this may not be possible.